Gayathri Diwakar
Head of Investor Relations
Replay available
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Founder and Chief Executive Officer
Chief Commercial Officer
Chief Medical and Development Officer
Chief Financial Officer
Chief Endocrinologist
Analyst, Piper Sandler
Analyst, J.P. Morgan
Watch the replay and follow the connected company analysis, news, and investor updates for Crinetics Pharmaceuticals, Inc..
WEBVTT 00:00:00.875 -- 00:00:05.839 Welcome to the Chronetics Pharmaceuticals First Quarter 2025 Financial Results Conference 00:00:05.839 -- 00:00:09.743 Call. At this time, all participants are in listen-only mode. 00:00:09.743 -- 00:00:14.427 Following the management's prepared remarks, we will hold a question and answer session. 00:00:14.427 -- 00:00:17.850 Please press star followed by one on your telephone keypad. 00:00:17.850 -- 00:00:21.813 If you change your mind, please press star followed by two. 00:00:21.813 -- 00:00:26.978 I would now like to turn the call over to Gayathri Diwakar, Head of Investor Relations. 00:00:26.978 -- 00:00:29.438 Please go ahead. 00:00:29.680 -- 00:00:34.314 Thank you, Operator. Good afternoon, everyone, and thank you for joining us to discuss 00:00:34.314 -- 00:00:38.899 the first quarter 2025 results. Today on the call, we have Dr. 00:00:38.899 -- 00:00:42.762 Scott Struthers, Founder and Chief Executive Officer, Dr. 00:00:42.762 -- 00:00:47.967 Dana Pizzuti, Chief Medical and Development Officer, Isabel Calafonos, Chief 00:00:47.967 -- 00:00:51.771 Commercial Officer, and Toby Schilke, Chief Financial Officer. 00:00:51.771 -- 00:00:56.856 Dr. Alan Krasner, Chief Endocrinologist, will also be joining for 00:00:56.856 -- 00:01:02.542 the Q&A portion. Please note there is a slide deck for today's presentation, 00:01:02.542 -- 00:01:07.168 which is in the events and presentation section of the investors page on the Crunetics 00:01:07.168 -- 00:01:08.850 website. 00:01:08.850 -- 00:01:13.656 In addition, a press release was issued earlier today and is also available on the corporate 00:01:13.656 -- 00:01:15.656 website. 00:01:15.959 -- 00:01:21.265 Slide two. As a reminder, we will be making forward looking statements and I invite ...